Rezolute, Inc.
Status: Publicly traded
Direct answer
Rezolute, Inc. is publicly traded on NASDAQ under the ticker RZLT.
Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of...
Can you invest in Rezolute, Inc.?
Yes. Rezolute, Inc. is publicly traded on NASDAQ under the ticker RZLT.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Rezolute, Inc.
Detailed equity research is provided by MarketSnap.